A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity

Eric D. Laing; Spencer L. Sterling; Stephanie A. Richard; Shreshta Phogat; Emily C. Samuels; Nusrat J. Epsi; Lianying Yan; Nicole Moreno; Christian Coles; Jennifer Mehalko; Matthew Drew; Caroline English; Kevin K. Chung; G. Travis Clifton; Vincent Munster; Emmie de Wit; David Tribble; Brian Agan; Dominic Esposito; Charlotte Lanteri; Edward Mitre; Timothy H. Burgess; Christopher C. Broder.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20207050

Documentos relacionados

  1. A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity.
  2. Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
  3. Evaluation of three fully-automated SARS-CoV-2 antibody assays.
  4. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses.
  5. A comparative phylogenomic analysis of SARS-CoV-2 strains reported from non-human mammalian species and environmental samples.
  6. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2.
  7. Continuous evolution and emerging lineage of seasonal human coronaviruses: A multicenter surveillance study.
  8. Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
  9. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
  10. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.